We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > Psychedelics

Psychedelics

Is Ayahuasca Safe? We Ask a Researcher

Dr. Perkins spoke with Technology Networks – the sister publication of Analytical Cannabis – to provide context on the latest research study and the next steps for the research group.

Read More

International Regulatory Developments For Key Psychedelics

Stephen Wright breaks down the lengthy process of getting a psychedelic medicine approved in the US.

Read More

Most Ayahuasca Users Vomit, Study Finds

Acute physical health adverse effects were reported by 69.9% of the study's participants.

Read More

The Dark Side of Psychedelic Trials

Dr. Markus Roggen, president and chief science officer of Vancouver-based Delic Labs, delves into the less favorable side of psychedelic research.

Read More

Colorado Votes to Decriminalize Most Psychedelics and Regulate Psilocybin Therapy

Once enacted, the proposal will give any adult in the state, aged 21 and over, the legal right to possess, use, cultivate and share psilocybin, ibogaine, mescaline (not derived from peyote), DMT, and psilocyn without fear of arrest.

Read More

Microdosing LSD Boosts the Brain’s Reward System, Study Finds

A new study has found that a single microdose of LSD can increase brain activity related to its reward system.

Read More

Psilocybin and Psychotherapy Relieve Treatment-Resistant Depression in Largest Clinical Trial to Date

The largest study to date testing the ability of the psychedelic compound psilocybin to treat a psychiatric disorder has shown that the mushroom-derived drug, delivered in combination with integrative psychotherapy sessions, significantly reduced participants’ depression as compared to a placebo after three weeks.

Read More

Synthetic Psychedelic Compounds May Treat Depression Without the Trip, Study Suggests

Scientists have developed a new compound which interacts with the same therapeutic targets in the brain as psychedelic drugs, producing the same long-lasting antidepressant and antianxiety effects but without the psychedelic high.

Read More

Alberta to Regulate Psychedelic-Assisted Therapy

Alberta will become the first province in Canada to regulate psychedelic-assisted therapy.

Read More

 
Advertisement